Kim Sablich

Kim Sablich

Plus aucun poste en cours
57 ans
Health Technology
Consumer Services
Technology Services

Profil

Kim Sablich formerly worked at Eiger BioPharmaceuticals, Inc., as Independent Director from 2021 to 2024, AllerGenis LLC, as Director from 2018 to 2021, GSK Plc, as Vice President from 2015 to 2018, Jazz Pharmaceuticals Plc, as Executive VP & General Manager-North America from 2020 to 2023, Myovant Sciences, Inc., as Chief Commercial Officer from 2018 to 2020, and Myovant Sciences Ltd., as Chief Commercial Officer from 2018 to 2020.
Ms. Sablich received her undergraduate degree from Denison University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.

Anciens postes connus de Kim Sablich

SociétésPosteFin
EIGER BIOPHARMACEUTICALS Directeur/Membre du Conseil 01/09/2024
JAZZ PHARMACEUTICALS PLC Corporate Officer/Principal 31/12/2023
Directeur/Membre du Conseil 01/04/2021
MYOVANT SCIENCES LTD. Corporate Officer/Principal 11/05/2020
Corporate Officer/Principal 01/05/2020
Voir l'expérience en détail de Kim Sablich

Formation de Kim Sablich

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

  1. Bourse
  2. Insiders
  3. Kim Sablich
🔇